Princeton, California3 days ago
D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.
We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients.
At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. The role is responsible for leading the budgeting and forecasting processes, overseeing financial performance analysis, ensuring the integrity of financial reporting and planning activities, and continuously enhancing FP&A processes and tools to improve the quality, reliability, and relevance of financial information across the organization. .